People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Biotechnology, Biotech / Pharma, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| JumpCode Genomics, Inc. | — | Biotechnology | Series B | $38.7M | $23.4M | 2020 |
| Swift Biosciences, Inc. | — | Biotech / Pharma | Series A | $31.5M | $134.0M | 2017 |
| BrightSpec, Inc. | — | Other Technology | Series A | $17.1M | $15.5M | 2022 |
| Akadeum Life Sciences, Inc. | — | Other Health Care | Series A | $15.4M | $20.5M | 2023 |
Dan Kidle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dan Kidle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Lewis | 1 | 15 |
| Paul Brown | 1 | 12 |
| Jack Ball | 1 | 10 |
| Thomas Jones | 1 | 10 |
| Michael Liang | 1 | 9 |
| William Wood | 1 | 9 |
| Eugene Chen | 1 | 9 |
| Dan Watkins | 1 | 8 |
| Keith Brown | 1 | 8 |
| Court Turner | 1 | 6 |
| Linda Tufts | 1 | 5 |
| George Dunbar | 1 | 5 |
| Jenny Rooke | 1 | 5 |
| Kevin Li | 1 | 4 |
| George Kastendike | 1 | 4 |
| Paul D'Amato | 1 | 4 |
| Robert Creeden | 1 | 4 |
| Walter Young | 1 | 3 |
| Nathan Wood | 1 | 3 |
| Frank Witney | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.